AstraZeneca PLC (LON: AZN)
12,042
-44 (-0.36%)
Jul 3, 2024, 8:45 AM GMT
AstraZeneca Revenue
AstraZeneca had revenue of $47.61B USD in the twelve months ending March 31, 2024, with 8.60% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.68B USD with 16.55% year-over-year growth. In the year 2023, AstraZeneca had annual revenue of $45.81B USD with 3.29% growth.
Revenue (ttm)
$47.61B
Revenue Growth
+8.60%
P/S Ratio
4.98
Revenue / Employee
$529,600
Employees
89,900
Market Cap
186.68B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | 24.38B | 2.29B | 10.38% |
Dec 31, 2018 | 22.09B | -375.00M | -1.67% |
Dec 31, 2017 | 22.47B | -537.00M | -2.33% |
Dec 31, 2016 | 23.00B | -1.71B | -6.90% |
Dec 31, 2015 | 24.71B | -1.39B | -5.32% |
Dec 31, 2014 | 26.10B | 384.00M | 1.49% |
Dec 31, 2013 | 25.71B | -2.26B | -8.09% |
Dec 31, 2012 | 27.97B | -5.62B | -16.72% |
Dec 31, 2011 | 33.59B | 322.00M | 0.97% |
Dec 31, 2010 | 33.27B | 465.00M | 1.42% |
Dec 31, 2009 | 32.80B | 1.20B | 3.81% |
Dec 31, 2008 | 31.60B | 2.04B | 6.91% |
Dec 31, 2007 | 29.56B | 3.08B | 11.65% |
Dec 31, 2006 | 26.48B | 2.53B | 10.54% |
Dec 31, 2005 | 23.95B | 2.52B | 11.78% |
Dec 31, 2004 | 21.43B | 2.58B | 13.67% |
Dec 31, 2003 | 18.85B | 999.19M | 5.60% |
Dec 31, 2002 | 17.85B | -5.72B | -24.27% |
Dec 31, 2001 | 23.57B | 5.45B | 30.11% |
Dec 31, 2000 | 18.12B | -319.97M | -1.74% |
Dec 31, 1999 | 18.44B | 9.29B | 101.57% |
Dec 31, 1998 | 9.15B | 559.73M | 6.52% |
Dec 31, 1997 | 8.59B | -597.90M | -6.51% |
Dec 31, 1996 | 9.18B | 1.62B | 21.35% |
Dec 31, 1995 | 7.57B | 564.40M | 8.06% |
Dec 31, 1994 | 7.00B | 436.39M | 6.64% |
Dec 31, 1993 | 6.57B | 532.74M | 8.83% |
Dec 31, 1992 | 6.03B | -1.32B | -17.91% |
Dec 31, 1991 | 7.35B | 2.64M | 0.04% |
Dec 31, 1990 | 7.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GSK plc | 30.74B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.39B |
ConvaTec Group Plc | 1.69B |
Hikma Pharmaceuticals PLC | 2.27B |
Oxford Nanopore Technologies plc | 254.50M |
Animalcare Group plc | 74.35M |
Shell plc | 238.85B |
AstraZeneca News
- 17 hours ago - Insights Into Merck & Co's Performance Versus Peers In Pharmaceuticals Sector - Benzinga
- 1 day ago - FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse - Benzinga
- 1 day ago - AstraZeneca COVID prevention antibody gets EU fast-track review - Seeking Alpha
- 2 days ago - AstraZeneca's COVID prevention drug application gets EU fast-track assessment - Reuters
- 2 days ago - Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2 - Seeking Alpha
- 4 days ago - Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector - Benzinga
- 5 days ago - German vaccine panel endorses Astra-Sanofi's RSV shot for infants - Reuters
- 6 days ago - China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients - Benzinga